Smart Medical Implant System with Integrated Technologies
Legal Citation
Summary of the Inventive Concept
A novel medical implant system that combines an improved subcutaneous medical implant with IoT, AI, blockchain, and advanced materials to provide personalized, real-time, and secure drug delivery.
Background and Problem Solved
The original patent addressed the issue of initial drug 'burst' in existing drug implants, but limitations remained in terms of real-time monitoring, data security, and adaptability to individual patients. The new inventive concept overcomes these limitations by integrating distinct technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The system comprises an implantable medical drug delivery device with a non-homogenous mixture of at least two different types of drug materials. This device is integrated with a wearable IoT sensor that monitors the patient's vital signs and adjusts the drug delivery rate accordingly. An AI-powered algorithm optimizes drug delivery by integrating data from the implantable device and the patient's electronic health record. The system utilizes a blockchain-based infrastructure for secure and tamper-proof data storage. Additionally, the device features a composite material with enhanced mechanical strength and drug release properties. A smart implantable medical drug delivery device with a microelectromechanical system (MEMS) and a piezoelectric material provides real-time monitoring and control of drug delivery.
Novelty and Inventive Step
The new claims introduce the innovative integration of IoT, AI, blockchain, and advanced materials with the original medical implant, providing a synergistic combination that offers unprecedented real-time monitoring, adaptability, and security in drug delivery.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different AI algorithms, various IoT sensors, or alternative blockchain architectures. Variations could also involve integrating the system with other medical devices, such as insulin pumps or pacemakers, or using different composite materials for the implantable device.
Potential Commercial Applications and Market
The smart medical implant system has significant commercial potential in the healthcare industry, particularly in the areas of chronic disease management, personalized medicine, and medical device security. The system could be marketed to pharmaceutical companies, medical device manufacturers, and healthcare providers, offering a competitive advantage in terms of patient outcomes and cost savings.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0024 |
| A | A61 | A61K31/4468 |
| A | A61 | A61K31/485 |
| A | A61 | A61K45/06 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically implantable drug delivery systems with a focus on controlled pharmaceutical release mechanisms, requiring advanced knowledge of materials science, biomedical engineering, and pharmaceutical formulation techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or pharmaceutical scientist with a graduate degree, expertise in drug delivery systems, familiarity with microelectronics, materials engineering, and experience designing medical implantable devices
Obviousness Rationale
A PHOSITA would recognize that integrating IoT, AI, and advanced monitoring technologies with existing drug delivery implants represents a predictable technological evolution. The source patent's non-homogenous drug matrix provides a foundational platform for enhanced drug delivery control, which the PTD extends through digital monitoring and adaptive algorithms. The technical variations represent incremental improvements using known interdisciplinary techniques that would be obvious to combine.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,671 |
|---|---|
| Title | Medical implant |